KEGG: clu:CLUG_00781
STRING: 306902.XP_002619622.1
GET1 functions as a membrane receptor component of the Guided Entry of Tail-anchored proteins (GET) pathway, which mediates the insertion of tail-anchored proteins into the endoplasmic reticulum membrane. In C. lusitaniae, GET1 forms a complex with GET2 that serves as the membrane receptor for the GET3-substrate complex.
To investigate GET1 conservation between species:
Perform phylogenetic analyses comparing C. lusitaniae GET1 with homologs from other Candida species
Generate multiple sequence alignments to identify conserved domains
Use structural prediction software to model the transmembrane domains
Recent studies of stress responses in C. lusitaniae reveal complex adaptation mechanisms to various cellular stressors, suggesting GET1 may play a similar critical role in ER homeostasis as observed in other species .
GET1 likely contributes to ER stress responses by ensuring proper insertion of tail-anchored proteins involved in the Unfolded Protein Response (UPR). While GET1 itself hasn't been specifically characterized in C. lusitaniae ER stress, related ER stress research in Candida species provides context:
The ER stress-induced UPR pathway in Candida species is comprised of the conserved ER-resident transmembrane protein kinase Ire1 and downstream transcription factors
When ER homeostasis is disrupted, the UPR is activated to restore balance by:
Increasing chaperone production
Expanding ER volume
Upregulating ER-associated degradation
Dysfunction in GET pathway proteins likely exacerbates ER stress by causing mislocalization of tail-anchored proteins
Research methodology:
Compare expression profiles of GET1 under normal conditions versus various ER stressors (tunicamycin, DTT)
Generate GET1 deletion mutants and assess their sensitivity to ER stress-inducing agents
Monitor UPR activation markers (HAC1 splicing, chaperone induction) in GET1 mutants
Expressing membrane proteins like GET1 presents unique challenges. Based on established protocols for similar proteins:
Expression system options:
E. coli expression system
BL21(DE3) or C41/C43(DE3) strains (specialized for membrane proteins)
Use vectors with tightly controlled promoters (pET or pBAD series)
Optimal induction: 0.1-0.5 mM IPTG at 18-20°C for 16-20 hours
Yeast expression systems
S. cerevisiae or P. pastoris systems may provide more native-like processing
Use strong inducible promoters (GAL1 for S. cerevisiae; AOX1 for P. pastoris)
Include C-terminal purification tags (His6, FLAG) with TEV cleavage sites
Membrane protein solubilization strategies:
Detergents: n-Dodecyl-β-D-maltoside (DDM), LMNG, or digitonin
Nanodiscs or amphipols for maintaining native-like environment
Optimization protocol:
Perform small-scale expression tests varying temperature, inducer concentration, and time
Analyze expression by Western blot with anti-tag antibodies
Assess membrane localization via fractionation studies
Purifying membrane proteins requires specialized approaches to maintain structural integrity and function:
Recommended purification workflow:
Membrane preparation
Lyse cells by mechanical disruption (French press or sonication)
Isolate membrane fraction by ultracentrifugation (100,000×g, 1h)
Solubilize membranes in buffer containing appropriate detergent
Affinity chromatography
IMAC (Immobilized Metal Affinity Chromatography) for His-tagged protein
Include detergent at CMC in all buffers
Elute with imidazole gradient (50-300 mM)
Size exclusion chromatography
Further purify by SEC using Superdex 200 column
Assess protein homogeneity and oligomeric state
Functional assessment
Reconstitute in proteoliposomes to test GET pathway activity
Verify interaction with GET2 and GET3 via pull-down assays
Critical parameters to monitor:
Detergent concentration (maintain above CMC)
Temperature (maintain at 4°C throughout purification)
Buffer composition (pH 7.5-8.0, 150-300 mM NaCl, 5-10% glycerol)
Presence of stabilizing agents (cholesterol hemisuccinate for membrane proteins)
To confirm that purified GET1 retains its native function:
In vitro reconstitution assays:
Proteoliposome reconstitution
Incorporate purified GET1 (with or without GET2) into liposomes
Measure binding of fluorescently labeled GET3
Quantify using fluorescence anisotropy or microscale thermophoresis
ATPase stimulation assay
Measure GET3 ATPase activity in presence vs. absence of GET1/GET2 complex
Use colorimetric phosphate detection methods (malachite green)
Binding assays:
Surface Plasmon Resonance (SPR)
Immobilize GET1 on sensor chip
Measure binding kinetics with GET3 and substrate proteins
Bio-Layer Interferometry (BLI)
Alternative to SPR for real-time binding measurements
Allows measurement of on/off rates
Structural verification:
Circular Dichroism (CD) spectroscopy
Verify secondary structure composition
Monitor thermal stability
Limited proteolysis
Assess proper folding by resistance to proteolytic digestion
Compare digestion patterns with known functional homologs
Recent research in Candida species has revealed cross-talk between ER stress pathways and the High-Osmolarity Glycerol (HOG) MAPK pathway. While specific GET1-HOG interactions aren't yet characterized in C. lusitaniae, evidence suggests potential connections:
In C. albicans, Hog1 is activated during the late phase of ER stress response and contributes to UPR attenuation
Hog1 phosphorylation during ER stress depends on both functional Ire1 and the Ssk1 mediator branch
GET pathway dysfunction may trigger both UPR and HOG pathway activation
Methodological approach to investigate GET1-HOG pathway crosstalk:
Generate GET1 deletion or conditional mutants in C. lusitaniae
Monitor Hog1 phosphorylation status under ER stress conditions (±GET1)
Perform epistasis analysis with double mutants (get1Δ hog1Δ)
Use RNA-Seq to compare transcriptional profiles of:
Wild-type under ER stress
GET1 mutants under normal and stress conditions
HOG1 mutants under normal and stress conditions
The results could be analyzed in the context of known HOG pathway functions during stress, such as glycerol production, which shifts protein folding equilibrium toward native conformations .
Given the relationship between ER function and stress adaptation in pathogenic fungi, GET1 mutations may influence antifungal susceptibility through several mechanisms:
Potential impacts on drug resistance:
Altered ER proteostasis affecting ergosterol biosynthesis enzymes
Impaired trafficking of multidrug resistance transporters
Changes in cell wall composition due to altered secretory pathway
Research methodology to investigate:
Generate GET1 variant library:
Use site-directed mutagenesis to create point mutations
Develop CRISPR-Cas9 system for C. lusitaniae to generate precise genomic edits
Assess antifungal susceptibility patterns:
Determine MICs using CLSI broth microdilution method
Perform time-kill assays for different drug classes
Assess synergy between ER stressors and antifungals
Correlate with clinical isolate data:
Screen clinical C. lusitaniae isolates for GET1 variations
Compare MIC data with genotypic changes
Current research on C. lusitaniae has demonstrated its propensity to rapidly develop resistance to multiple antifungal drugs including amphotericin B, azoles, and echinocandins , suggesting complex stress adaptation mechanisms that might involve ER trafficking pathways.
The MRR1 transcription factor has been extensively studied in C. lusitaniae for its role in antifungal resistance and stress responses . Potential interactions with GET1 function could reveal important regulatory connections:
MRR1 regulates multiple genes involved in stress response, including:
GET1 dysfunction could potentially trigger compensatory changes in MRR1-regulated pathways
Research approach to investigate interactions:
Transcriptomic analysis:
Compare RNA-Seq profiles of GET1 mutants vs. wild-type
Identify overlaps with known MRR1 regulon
Genetic interaction studies:
Create GET1 and MRR1 single and double mutants
Assess phenotypes under various stress conditions
Perform chemical genetic screens
Protein localization studies:
Determine if any MRR1-regulated proteins are GET pathway substrates
Track localization of fluorescently tagged tail-anchored proteins in GET1 and MRR1 mutant backgrounds
This research could reveal whether gain-of-function mutations in MRR1, which confer fluconazole resistance but hydrogen peroxide sensitivity , affect GET pathway function and ER homeostasis in C. lusitaniae.
C. lusitaniae isolates show heterogeneity in oxidative stress resistance, particularly regarding hydrogen peroxide sensitivity . GET1 may contribute to this phenotype through:
Proper targeting of tail-anchored antioxidant proteins to the ER
Maintenance of ER homeostasis during oxidative stress
Coordination with other stress response pathways
| Genetic Background | H₂O₂ Resistance | FLZ Resistance | Reference |
|---|---|---|---|
| Wild-type | Moderate | Moderate | |
| MRR1 GOF mutations | Low | High | |
| MRR1 deletion | High | Variable | |
| MDR1 deletion | High | Low | |
| GET1 deletion | ? | ? | Not determined |
Research methodology:
Generate GET1 deletion and conditional expression strains
Assess H₂O₂ sensitivity using:
Disk diffusion assays
Growth curve analysis in subinhibitory H₂O₂ concentrations
ROS accumulation measurements (DCF-DA fluorescence)
Determine whether GET1 dysfunction affects localization of oxidative stress response proteins
Investigate GET1 expression patterns in clinical isolates exposed to host-derived oxidative stress
This research would be particularly relevant given the trade-offs observed between antifungal resistance and oxidative stress resistance in C. lusitaniae isolates from chronic infections .